Table 3. Summary of literature on difference in mortality with CVC and AVF.
Study | Mean age | Mortality with AVF (per 100 PY) | Mortality with CVC (per 100 PY) | Population |
Dhingra (2001) Diabetes | 59.2 | 13* | 22* | Prevalent, DMMS Wave 1 |
Dhingra (2001) No Diabetes | 59.2 | 11* | 23* | Prevalent, DMMS Wave 1 |
Pastan (2002) | 58.3±0.2 | 7.29 | 15.16 | Prevalent ESRD Network 6 |
Xue (2003) First 90 days | ∼75 | 28.8 | 60.4 | Incident Medicare |
Xue (2003) Next 9 months | ∼75 | 21.6 | 52.8 | Incident Medicare |
Polkinghorne (2004) | 61 (range 48–71) | 8.6 | 26.1 | Incident |
Moist (2008) | 68 (median) | HR 1.6† | Incident | |
Bradbury (2009) | 62.5±15 | 9.96‡ | 53.62‡ | Incident, DOPPS I & II |
*Adapted from Adjusted patient survival data.
Hazard ratio, compared to mortality with AVF.
Six month follow up data.
PY: patient-years.